IntegraGen S.A.
$0.19▼ 1.83%($-0.00)
TickerSpark Score
48/100
▌ Weak
73
Valuation
40
Profitability
10
Growth
56
Health
60
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALINT.PA research report →
52-Week Range18% of range
Low
$0.12
Current
$0.19
High
$0.52
Company Overviewintegragen.com
About the company
IntegraGen S. A. provides advanced human genome analysis services to academic researchers and life science businesses across France.
- CEO
- Berengere Genin
- IPO
- 2010
- Employees
- 44
- HQ
- Évry, FR
Price Chart
-62.25% · this period
Valuation
- Market Cap
- $1.24M
- P/E
- -0.48
- P/S
- 0.25
- P/B
- -1.42
- EV/EBITDA
- -0.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -47.22%
- Op Margin
- -56.21%
- Net Margin
- -53.06%
- ROE
- 933.16%
- ROIC
- -357.59%
Growth & Income
- Revenue
- $5.02M · -42.27%
- Net Income
- $-2,664,000 · -940.63%
- EPS
- $-0.40 · -952.63%
- Op Income
- $-2,822,402
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.52
- 52W Low
- $0.12
- 50D MA
- $0.20
- 200D MA
- $0.17
- Beta
- 0.35
- Avg Volume
- 32.32K
Get TickerSpark's AI analysis on ALINT.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · ALINT.PA
Our ALINT.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on ALINT.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALINT.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.